COMMUNIQUÉS West-GlobeNewswire

DiaMedica Announces Positive Results From FDA Meeting on Planned Clinical Trial in Patients with Chronic Kidney Disease
03/05/2018
DiaMedica has received final minutes from Type B meeting with the US FDA DiaMedica preparing to submit an IND to initiate DM199 clinical study in patients with chronic kidney disease in the US MINNEAPOLIS, May 03, 2018 [...]
Israeli Cancer Research Firm Vaxil Granted 9th Patent for Immunotherapy Treatment
03/05/2018
Provides Corporate Update ISRAEL and TORONTO, May 03, 2018 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (TSX VENTURE:VXL), a cancer research biotechnology company focused on innovative immunotherapy treatments, has been granted a [...]
Surgery Partners, Inc. Announces First Quarter 2018 Earnings Release Date and Conference Call Details
03/05/2018
NASHVILLE, Tenn., May 03, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that the Company will release its [...]
Moleculin Announces Engagement with Voisin Consulting Life Sciences to Expand Annamycin Clinical Trial
03/05/2018
HOUSTON, May 03, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX ) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
Scythian Announces Marigold’s Exclusive Agreement with Jamaica’s Peter Tosh Museum
03/05/2018
— Medicinal Cannabis Dispensary to open in Peter Tosh Square — — Peter Tosh Square to be the home of Marigold ’s first herb house — TORONTO, May 03, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " [...]
Viveve to Announce First Quarter 2018 Financial Results
03/05/2018
Conference Call and Webcast Scheduled for Thursday, May 10, 2018 ENGLEWOOD, Colo., May 03, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE ), a medical technology company focused on women's intimate health, [...]
William Demant Holding A/S: Completion of capital reduction
03/05/2018
Company announcement no 2018-05 3 May 2018 Completion of capital reduction in William Demant Holding A/S As stated in Company announcement no. 2018-04, it was decided at William Demant Holding A/S’ ordinary general [...]
Organovo and Samsara Sciences Partner with New Manufacturing USA Institute
03/05/2018
The Advanced Regenerative Manufacturing Institute (ARMI) will receive nearly $300 million in public-private investment from leading manufacturers, universities, nonprofit organizations and the federal government to [...]
Shire plc : Director/PDMR Shareholding
03/05/2018
Director/PDMR Shareholding May 3, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging managerial [...]
Iovance Biotherapeutics to Host First Quarter 2018 Financial Results Conference Call and Webcast on Thursday, May 10, 2018
03/05/2018
SAN CARLOS, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology [...]
Evolus to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
03/05/2018
IRVINE, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS ) (“Evolus”), a lifestyle aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians and consumers, [...]
Five million doses of Prevtec Microbia’s bivalent vaccine Coliprotec® F4/F18 Sold in the European Union
03/05/2018
MONTREAL, May 03, 2018 (GLOBE NEWSWIRE) -- Prevtec Microbia Inc. (“Prevtec”) is pleased to announce that five million doses of its bivalent vaccine Coliprotec® F4/F18 have been sold in the European Union (EU) since its [...]
Prevtec Microbia atteint le seuil de cinq millions de doses vendues en Union Européenne pour son vaccin bivalent Coliprotec® F4/F18
03/05/2018
MONTRÉAL, 03 mai 2018 (GLOBE NEWSWIRE) -- Prevtec Microbia Inc. (« Prevtec ») a le plaisir d’annoncer que son vaccin bivalent Coliprotec® F4/F18 a atteint le seuil de cinq millions de doses vendues en Union Européenne ( [...]
Onconova Therapeutics to Present at the Disruptive Growth and Healthcare Conference on May 8th, 2018
03/05/2018
NEWTOWN, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary [...]
Pieris Pharmaceuticals to Present at 43rd Annual Deutsche Bank Health Care Conference
03/05/2018
BOSTON, May 03, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS ) , a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for cancer, [...]
CASMED to Report First-Quarter 2018 Financial Results and Hold Conference Call on May 10
03/05/2018
BRANFORD, Conn., May 03, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for [...]
Athenex, Inc. to Report First Quarter Earnings Results on May 14, 2018
03/05/2018
BUFFALO, N.Y., May 03, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
T2 Biosystems Reports Granting of Inducement Awards
03/05/2018
LEXINGTON, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]
Fibrocell to Host Conference Call and Webcast on Thursday, May 10, 2018 to Discuss First Quarter 2018 Financial Results and Recent Highlights
03/05/2018
EXTON, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, will [...]

Pages